32 results
8-K
EX-10.1
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
to the transactions contemplated under this Agreement). Seller shall retain all Tax books and records and abide by all record retention agreements entered
DEFM14A
ELYM
Eliem Therapeutics Inc
4 Jun 24
Proxy related to merger
8:00am
$1.24 for both fiscal years 2022 and 2023.
Represents a retention bonus of $261,323 paid in 2023 as well as the amount of company contributions … , Eliem entered into a retention agreement with Dr. Morisset which provided for (i) an increase in Dr. Morisset’s base salary from £336,190 to £420,238
PREM14A
ELYM
Eliem Therapeutics Inc
17 May 24
Preliminary proxy related to merger
4:36pm
to US$1.24 for both fiscal years 2022 and 2023.
Represents a retention bonus of $261,323 paid in 2023 as well as the amount of company contributions … , 2023, Eliem entered into a retention agreement with Dr. Morisset which provided for (i) an increase in Dr. Morisset’s base salary from £336,190
DEFA14A
2e9na0xjl3 mg6dce3a
11 Apr 24
Additional proxy soliciting materials
8:10am
8-K
EX-2.1
6nl8h
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
8-K
EX-99.1
cmsran1u24pgbb50c
18 Mar 24
Other Events
6:34pm
8-K
EX-99.2
eeja7qssocrfk8
11 May 23
Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights
4:12pm
10-K
lqhermj dtm
7 Mar 22
Annual report
4:03pm
10-Q
o9t0wl cpytqgnu2
13 Sep 21
Quarterly report
4:01pm